Recombinant human growth hormone (Kexing)

人生长激素(Kexing)

Report date: 2026/05/02 20:00:18

Base Information

Drug NameRecombinant human growth hormone (Kexing)
Drug Alias NameGB06GB-06
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyGrowth DisordersDwarfism, Pituitary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShenzhen Kexing Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Kexing Bio-Products Co Ltd
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiencyGrowth DisordersDwarfism, Pituitary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A